SEC Form 4 · accession 0000899243-15-007902
Emergent BioSolutions Inc. · EBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Fuad El-Hibri
Officer — Chairman · Director · 10% Owner
Period of report
Nov 9, 2015
Accepted (ET)
Nov 10, 2015 · 7:04 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 9, 2015 | M | 20,000 | $18.90 | A | 1,848,493 | D | |
| Common Stock | Nov 9, 2015 | S | 13,225 | $35.50 | D | 1,835,268 | D | |
| Common StockF3 | holding | — | — | — | 2,350,331 | I | By Intervac, L.L.C. | |
| Common StockF4 | holding | — | — | — | 1,524,155 | I | By Biovac, L.L.C. |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF5 | $18.90 | Nov 9, 2015 | M | 20,000 | D | — | Mar 9, 2016 | Common Stock | 20,000 | 47,900 | D |
Explanation of responses
- F1Consists of an option granted under the company's stock incentive plan on March 10, 2009.
- F2All sales listed on this Form 4 were made by the Reporting Person pursuant to a plan adopted on May 11, 2015 that is intended to comply with Rule 10b5-1(c) under the Exchange Act.
- F3Mr. El-Hibri's holdings through Intervac, L.L.C. include 1,638,403 shares of Common Stock held by Mr. El-Hibri and his wife, as tenants by the entirety, through their 37.7% equity interest in Intervac, L.L.C.; 127,721 shares held by Mr. El-Hibri's wife; and 584,207 shares held by trusts indirectly controlled by Mr. El-Hibri or his wife. Mr. El-Hibri disclaims beneficial ownership, for purposes of Section 16 of the Exchange Act or otherwise, of those shares held solely by his wife and those shares held by the trusts.
- F4Mr. El-Hibri holds individually and with his wife, as tenants by the entirety, an aggregate 89.2% equity interest in Biovac, L.L.C. Biovac, L.L.C. is the direct owner of 1,524,155 shares of Common Stock. Mr. El-Hibri disclaims beneficial ownership of the shares of Common Stock directly owned by Biovac, L.L.C. for purposes of Section 16, except to the extent of his pecuniary interest in 1,359,546 shares.
- F5The option vested in three equal installments on March 9, 2010, March 9, 2011 and March 9, 2012.